Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts
- 15 January 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (2) , 354-360
Abstract
Li-Fraumeni syndrome (LFS) is a rare hereditary cancer syndrome associated with an autosomal-dominant mutation inheritance in the TP53 tumor suppressor gene and a wide spectrum of cancer diagnoses. The previously developed R package, LFSPRO, is capable of estimating the risk of an individual being a TP53 mutation carrier. However, an accurate estimation of the penetrance of different cancer types in LFS is crucial to improve the clinical characterization and management of high-risk individuals. Here, we developed a competing risk-based statistical model that incorporates the pedigree structure efficiently into the penetrance estimation and corrects for ascertainment bias while also increasing the effective sample size of this rare population. This enabled successful estimation of TP53 penetrance for three LFS cancer types: breast (BR), sarcoma (SA), and others (OT), from 186 pediatric sarcoma families collected at MD Anderson Cancer Center (Houston, TX). Penetrance validation was performed on a combined dataset of two clinically ascertained family cohorts with cancer to overcome internal bias in each (total number of families = 668). The age-dependent onset probability distributions of specific cancer types were different. For breast cancer, the TP53 penetrance went up at an earlier age than the reported BRCA1/2 penetrance. The prediction performance of the penetrance estimates was validated by the combined independent cohorts (BR = 85, SA = 540, and OT = 158). Area under the ROC curves (AUC) were 0.92 (BR), 0.75 (SA), and 0.81 (OT). The new penetrance estimates have been incorporated into the current LFSPRO R package to provide risk estimates for the diagnosis of breast cancer, sarcoma, or other cancers. Significance: These findings provide specific penetrance estimates for LFS-associated cancers, which will likely impact the management of families at high risk of LFS. See related article by Shin et al., p. 347Keywords
Funding Information
- Cancer Prevention Research Institute of Texas (RP130090)
- National Research Foundation of Korea (2019R1A4A1028134)
- NCI (1R01 CA183793, 1R01 CA174206, 2R01 CA158113)
- NCI (P30CA016672)
- NCI (3P50CA196530, 3P30CA016359)
- NCI (1R01 CA183793)
- NIH (P01CA34936)
- Cancer Institute NSW (2018/CDF004)
- NHMRC (1104364, GNT1125042)
- NCI (1U01CA196386, CA196386S1, 1R01CA186566)
- CPRIT (RR170048)
- NCI (U19CA203654, U19CA203654S1)
- University of Texas MD Anderson Cancer Center (CA016672)
This publication has 32 references indexed in Scilit:
- High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma CohortPLOS ONE, 2013
- The rebel angel: mutant p53 as the driving oncogene in breast cancerCarcinogenesis, 2012
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Effects of measured susceptibility genes on cancer risk in family studiesHuman Genetics, 2009
- Joint Effects of Germ-Line p53 Mutation and Sex on Cancer Risk in Li-Fraumeni SyndromeCancer Research, 2006
- Population-Calibrated Gene CharacterizationJournal of the American Statistical Association, 2005
- BayesMendel: an R Environment for Mendelian Risk PredictionStatistical Applications in Genetics and Molecular Biology, 2004
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer riskHuman Genetics, 2003
- The Genetic Implications of Long-Term Survival of Childhood Cancer: A Conceptual FrameworkJournal of Pediatric Hematology/Oncology, 1987